Advertisement
MO BIO
MO BIO

Most Recent

image: All In Proportion

All In Proportion

By | March 2, 2013

Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.

0 Comments

image: Contributors

Contributors

By | March 1, 2013

Meet some of the people featured in the March 2013 issue of The Scientist.

0 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

During development, communication between organs determines their relative final size.

2 Comments

image: Fellow Travelers

Fellow Travelers

By | February 1, 2013

Collective cell migration relies on a directional signal that comes from the moving cluster, rather than from external cues.

1 Comment

image: Go Forth, Cells

Go Forth, Cells

By | February 1, 2013

Watch the cell transplant experiments in zebrafish that suggest certain embryonic cells rely on intrinsic directional cues for collective migration.

0 Comments

image: Some Insurers Protected by GINA

Some Insurers Protected by GINA

By | January 23, 2013

Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.

2 Comments

image: Failing Alzheimer’s Test?

Failing Alzheimer’s Test?

By | December 19, 2012

Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.

0 Comments

image: 2012 Multimedia Roundup

2012 Multimedia Roundup

By | December 14, 2012

The science images and videos that captured our attention in 2012

1 Comment

image: From Urine to Neurons

From Urine to Neurons

By | December 11, 2012

Scientists have developed new method for generating brain cells from urine, speeding up the process and eliminating some of the problems with previous techniques.

1 Comment

image: Neurologist Reveals Insider Information

Neurologist Reveals Insider Information

By | November 26, 2012

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies